Condition
Malignant Tumor|Treatment Resistant Disorders|Tumor Progression
Estimated Enrollment: 32
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: Eu-nr 2006-004076-13
Study First Received: October 8, 2013
Last Updated: October 8, 2013
Estimated Primary Completion Date: October 2016
Primary Outcome Measures:
Maximal tolerable dose (phase I, ongoing)|Responses
Sponsors and Collaborators:
Karolinska University Hospital|Cancerfonden|Cancer and Allergy Foundation|Cancerföreningen i Stockholm|Stockholm County Council, Sweden
Website Link: https://ClinicalTrials.gov/show/NCT01959438
